https://tie2-signaling.com/ind....ex.php/medical-diagn
A descriptive study investigated the use of intranasal ketamine as an acute treatment for refractory chronic migraine, observing a reduction in headache intensity and improvement in quality of life, accompanied by relatively manageable adverse events. Intranasal ketamine was effective for the majority of patients, who continued using it, even with the accompanying adverse events. In light of the potenti
Like
Comment
Share
